Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature

Agranulocytosis as a side effect of clozapine has been reported to be associated with initial phases of treatment, i.e., first six months. Agranulocytosis with clozapine during the initial phases of treatment has been linked to genetic vulnerability in the form of variations in the human leukocyte-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Aakanksha, Grover, Sandeep, Malhotra, Pankaj, Varma, Subhash C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857873/
https://www.ncbi.nlm.nih.gov/pubmed/27121434
http://dx.doi.org/10.9758/cpn.2016.14.2.212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857873/
https://www.ncbi.nlm.nih.gov/pubmed/27121434
http://dx.doi.org/10.9758/cpn.2016.14.2.212

Ejemplares similares